One-way ANOVA was used to compare the expression of PLAGL2 in different types of cancer cell lines (Barretina et al., 2012; Cancer Cell Line Encyclopedia Consortium and Genomics of Drug Sensitivity in Cancer Consortium, 2015). The gene discussed is PLAGL2; the disease is cancer.